PRECISION BIOSCIENCES INC Quarterly Operating Income (Loss) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Precision Biosciences Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q3 2024.
  • Precision Biosciences Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$21.3M, a 72.1% decline year-over-year.
  • Precision Biosciences Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$16.2M, a 17.3% increase year-over-year.
  • Precision Biosciences Inc annual Operating Income (Loss) for 2023 was -$43.7M, a 29.8% increase from 2022.
  • Precision Biosciences Inc annual Operating Income (Loss) for 2022 was -$62.3M, a 58.2% decline from 2021.
  • Precision Biosciences Inc annual Operating Income (Loss) for 2021 was -$39.4M, a 64.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$16.2M -$21.3M -$8.91M -72.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$7.29M $24.1M +$27.3M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$34.6M -$4.19M +$9.17M +68.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$43.7M -$14.9M -$24.1M -261% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$19.6M -$12.4M +$2.31M +15.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$21.9M -$3.13M +$26.4M +89.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$48.3M -$13.4M +$14M +51.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$62.3M $9.26M +$40M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$102M -$14.7M -$3.13M -27.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$99.2M -$29.6M -$51.2M -237% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$48M -$27.3M -$8.59M -45.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$39.4M -$30.7M -$7.24M -30.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$32.1M -$11.5M +$14.5M +55.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$46.6M $21.6M +$54.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$101M -$18.7M +$8.75M +31.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$110M -$23.5M -$1.62M -7.41% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$108M -$26M -$4.07M -18.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$104M -$32.8M -$8.94M -37.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$95.2M -$27.5M -$8M -41% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$87.2M -$21.9M -$5.76M -35.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$81.4M -$22M -$11.5M -110% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$69.9M -$23.9M -$11.7M -96.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$58.2M -$19.5M -$10.3M -111% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$47.9M -$16.1M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$10.4M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$12.1M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$9.24M Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.